Skip to main content
v2026.11,610 entries · CC-BY 4.0
LAC HealthLaboratory & ResearchLab & research supplies.Reagents, consumables, PPE & instruments — documented, fast, chain-of-custody shipping.Shop lac.us lac.us

Editorial · CASRAI · Research integrity and misconduct

Jason Arday Resigns From Cambridge as University Opens New Inquiry Into Qualifications

Jason Arday resigned his Cambridge professorship and Jesus College fellowship on 5 August 2026 as the university opened a new inquiry into his qualifications and honorary appointments, alongside a separate academic-misconduct review already underway.

Published 6 Aug 2026· Last updated 9 Aug 2026· 5 minute read

Ask about this story

Answers are drawn from this article and the rest of the CASRAI corpus, with a link to every source.

Answers are AI-generated from CASRAI’s own published pages and can be wrong, so check the linked sources before relying on one; your question is logged without personal data — never sold, never used to train a third-party model — to show us what CASRAI is missing, so please do not type personal or confidential details. How we use this

CASRAI is the reference for research administration — bookmark it for the next question.

Jason Arday, a professor of sociology at the University of Cambridge who became the youngest Black professor in the university’s history when he was appointed in 2023, resigned from his professorship and his fellowship at Jesus College “with immediate effect” on 5 August 2026. His resignation was announced as Cambridge confirmed it had opened a new inquiry into his academic qualifications and honorary appointments, separate from an existing academic-misconduct review that had already been underway. It is the second high-profile 2026 case in which a senior humanities or social-science scholar has left a post while an institutional review was live; the other is Kerri Greenidge’s departure from Tufts, which followed an externally commissioned review of her 2022 book.

This article reports only what has been stated by named sources or reported by named outlets. Where an allegation has not been resolved by a formal finding, it is described here as an allegation or as a matter under investigation, not as an established fact. Where Arday has responded on the record, his response is included.

What happened

According to reporting by Al Jazeera and NBC News, Arday stepped down from his Cambridge professorship and his fellowship at Jesus College on 5 August 2026, following weeks of public scrutiny over both his doctoral dissertation and personal claims he had made about athletic and fundraising achievements. Cambridge’s new inquiry, prompted by what both outlets describe as “new information” concerning his qualifications and honorary appointments, is reported to be running alongside an academic-misconduct review that predates it.

The new Cambridge inquiry

The university has not, based on available reporting, published a detailed public account of what the new inquiry covers beyond “new information” about Arday’s qualifications and his honorary appointments. That the university opened a second, distinct line of inquiry — rather than folding the new material into the misconduct review already in progress — is itself notable, and this article will be updated if Cambridge or Jesus College issue a fuller public statement on the inquiry’s scope or timeline.

The plagiarism allegations

The dissertation allegations were raised publicly by Nathan Cofnas, described in reporting as a former Cambridge research affiliate, who alleged that multiple sections of Arday’s doctoral dissertation had been copied from other works. This is an allegation, not a finding by any institutional investigative body reported here to date. See CASRAI’s dictionary entries on textual plagiarism and research misconduct for how research-integrity bodies typically define and distinguish these categories, and the guide on types of plagiarism for how dissertation-level copying claims are usually categorised and investigated.

The fundraising and athletic claims

Separately from the dissertation allegations, reporting has described discrepancies between claims Arday made about his personal athletic and fundraising achievements — including a claim to have run 30 marathons in 35 days and raised £5.5 million for charity — and what has been independently verifiable. These claims are described here as reported allegations under scrutiny, not as established fact, and this article does not assert a specific finding on them.

Liverpool John Moores University’s review

Liverpool John Moores University, which awarded Arday’s doctorate in 2015, is reported to have reviewed the dissertation allegations and to have attributed the issues it identified to “honest and reasonable error” rather than research misconduct. CASRAI has not independently verified the full text or scope of LJMU’s findings beyond what is reported by the sources cited above, and this article should not be read as a full account of that review.

Arday’s response

Arday has responded publicly to the allegations. He has acknowledged making academic “mistakes,” but has said he has been wrongly “portrayed to be a liar and a fantasist and an academic fraud,” and has described the sustained public scrutiny as taking a toll on him and his family. He has characterised the broader campaign against him as “racially motivated.” In his resignation statement, he described months of “relentless accusations, speculation and public commentary” as having become “unsustainable.” As of publication, no further public statement from Arday beyond what is reported above has been identified; this article will be corrected or updated if one is issued.

Cambridge’s shifting position

Reporting indicates that as recently as June 2026, Cambridge had publicly defended Arday against what the university then characterised as “a vile campaign” to undermine his credibility. The university’s position moved, over the following weeks, to opening a formal academic-misconduct review and then the further inquiry announced alongside Arday’s resignation. CASRAI has not identified a single consolidated public Cambridge statement covering that full timeline; the account here is drawn from the outlets cited.

What remains unresolved

As of this article’s publication, several things are unresolved and should not be treated as settled: the scope and eventual conclusions of Cambridge’s new inquiry into Arday’s qualifications and honorary appointments; the status of the separate academic-misconduct review reported to already be underway at Cambridge; and the athletic and fundraising claims under scrutiny, which are distinct from the dissertation-plagiarism allegations and appear not to have been the subject of a completed institutional finding at the time of writing. Readers should treat any claim of a completed “finding” of misconduct against Arday, beyond what is attributed to specific sources above, with caution until Cambridge, Jesus College, or another named investigative body publishes one.

For background on how UK and international institutions typically structure this kind of process, see CASRAI’s guides on how a research misconduct investigation works, institutional versus federal jurisdiction in research misconduct cases, and the consequences of a research misconduct finding, and the dictionary entry on the Committee on Publication Ethics (COPE), whose guidelines many UK universities reference when structuring misconduct and authorship investigations.

Related editorial in this domain

More on Research integrity and misconduct

8 Aug 2026

Study Finds the Brain Processes Language Complexity Even Under General Anesthesia

Baylor College of Medicine researchers recorded individual hippocampal neurons in epilepsy-surgery patients under general anesthesia and found the brain still distinguishes nouns, verbs, and adjectives, and even predicts upcoming words — evidence of structured language processing without consciousness. Because the data can only be collected while the patient is unconscious, all consent has to be obtained pre-operatively, a genuinely distinct human-subjects-ethics scenario from research where a participant can object in real time.

8 Aug 2026

Eye-Tracking Study Finds Early Attentional Marker of Depression Risk in Children

A two-year Binghamton University study tracking 242 children’s eye movements toward emotional faces found a measurable attention marker linked to depression risk — one that shifts differently depending on whether a child’s mother has a history of major depressive disorder. Because the study collects family mental-health-history data on minors and assesses inherited depression risk, it required heightened IRB review and parental consent, a genuine human-subjects-ethics angle.

8 Aug 2026

THC Medication Dronabinol Eliminates PTSD Nightmares for a Third of Patients in Industry-Funded Trial

In a Charité-led, double-blind, placebo-controlled trial of 170+ PTSD patients, the THC medication Dronabinol cut nightmare severity nearly twice as much as placebo over ten weeks, and more than a third of treated patients stopped having nightmares entirely. The trial was funded by Bionorica SE, a pharmaceutical manufacturer with a commercial stake in THC-based products — a genuine conflict-of-interest disclosure story — and its at-home, self-administered dosing design in a trauma-exposed population raises real research-ethics protocol questions.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →